A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 575 participants.
Also called NCT01674712
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 575 participants
- Sponsor
- Registry
-
NCT01674712 -
2011-005924-16
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, Czechia, Germany, Mexico, Poland, Romania, Russia
- Registry status
- Completed
Technical summary
Registry record NCT01674712. Randomized; quadruple masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-10-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
- Condition
- Dyslipidemia
- Intervention (Drug)
- Fixed Combination of Fenofibrate/simvastatin 145/20 mg
- Intervention (Drug)
- Simvastatin 20 mg
- Intervention (Drug)
- Fenofibrate 145 mg
- Intervention (Drug)
- Fixed Combination of Fenofibrate/simvastatin 145/40 mg
- Intervention (Drug)
- Simvastatin 40 mg
- Lead sponsor
- Abbott
Record details
- Record id
cardio:ct-nct01674712- Content hash
db4b2ea8dcfb15ef0fe978c8a151fc060eedb47b93261da7477bf86daef60657